| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
|
Lemmon, Christopher A.
|
|
|
3 |
7 |
p.
|
artikel
|
| 2 |
A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib
|
Schneider, Jaime L.
|
|
|
3 |
7 |
p.
|
artikel
|
| 3 |
Brief Report: Implementation of a Universal Prescreening Protocol to Increase Recruitment to Lung Cancer Studies at a Veterans Affairs Cancer Center
|
Xiang, Jenny J.
|
|
|
3 |
7 |
p.
|
artikel
|
| 4 |
Characteristics of and Treatment Strategies for Advanced EGFR-Mutant NSCLC With Concomitant BRAF Variations
|
Wei, Xue-Wu
|
|
|
3 |
7 |
p.
|
artikel
|
| 5 |
Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC
|
Noé, Johannes
|
|
|
3 |
7 |
p.
|
artikel
|
| 6 |
Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC: A Prospective Observational Study
|
Morimoto, Kenji
|
|
|
3 |
7 |
p.
|
artikel
|
| 7 |
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study
|
Kawachi, Hayato
|
|
|
3 |
7 |
p.
|
artikel
|
| 8 |
Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada
|
Thanh, Nguyen Xuan
|
|
|
3 |
7 |
p.
|
artikel
|
| 9 |
Impact of Socioeconomic Factors on Overall Survival in SCLC
|
Roof, Logan
|
|
|
3 |
7 |
p.
|
artikel
|
| 10 |
Lung Cancer Screening Knowledge and Perceived Barriers Among Physicians in the United States
|
Kota, Karthik J.
|
|
|
3 |
7 |
p.
|
artikel
|
| 11 |
National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients
|
Meza, Rafael
|
|
|
3 |
7 |
p.
|
artikel
|
| 12 |
Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer
|
Yeh, Yi-Chen
|
|
|
3 |
7 |
p.
|
artikel
|
| 13 |
Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report
|
Tanaka, Takaaki
|
|
|
3 |
7 |
p.
|
artikel
|
Tijdschrift beschrijving